We are live on ! Find out more
BA

Boston Advisors Portfolio holdings

AUM $1.91B
1-Year Est. Return 6.26%
This Fund
S&P 500
This Quarter Est. Return
+1.79%
1 Year Est. Return
+6.26%
3 Year Est. Return
+73.82%
5 Year Est. Return
+112.87%
10 Year Est. Return
AUM
$1.91B
AUM Growth
+$41.4M
Cap. Flow
+$28.5M
Cap. Flow %
1.49%
Top 10 Hldgs %
16.46%
Holding
683
New
51
Increased
235
Reduced
259
Closed
87

Top Sells

Rank Stock Value
1
ZION icon
Zions Bancorporation
ZION
+$7.18M
2
VZ icon
Verizon
VZ
+$5.96M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$5.6M
4
PEP icon
PepsiCo
PEP
+$5.53M
5
V icon
Visa
V
+$4.91M

Sector Composition

Rank Sector Weight
1 Technology 15%
2 Financials 12.68%
3 Healthcare 11.38%
4 Industrials 9.77%
5 Consumer Discretionary 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALL icon
76
Allstate
ALL
$64.8B
$6.55M 0.34%
60,254
+891
+2% +$93K
EXC icon
77
Exelon
EXC
$47B
$6.5M 0.34%
188,534
-19,126
-9% -$642K
BAX icon
78
Baxter International
BAX
$11.5B
$6.45M 0.34%
73,779
-8,064
-10% -$688K
SYK icon
79
Stryker
SYK
$121B
$6.41M 0.34%
29,654
-2,170
-7% -$465K
AMGN icon
80
Amgen
AMGN
$198B
$6.39M 0.33%
33,036
+593
+2% +$114K
HRC
81
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$6.36M 0.33%
60,411
-1,272
-2% -$134K
KMB icon
82
Kimberly-Clark
KMB
$35.9B
$6.29M 0.33%
44,263
+14,570
+49% +$2M
MRK icon
83
Merck
MRK
$312B
$6.25M 0.33%
77,787
-11,747
-13% -$941K
ABBV icon
84
AbbVie
ABBV
$452B
$6.25M 0.33%
82,489
-209
-0.3% -$14.3K
SYNH
85
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$6.24M 0.33%
117,336
+92,736
+377% +$4.76M
AMED
86
DELISTED
Amedisys
AMED
$6.23M 0.33%
47,529
+852
+2% +$111K
RVTY icon
87
Revvity
RVTY
$12.3B
$6.2M 0.32%
72,742
EHC icon
88
Encompass Health
EHC
$11.1B
$6.12M 0.32%
121,645
+4,084
+3% +$205K
CL icon
89
Colgate-Palmolive
CL
$72.4B
$6.02M 0.31%
81,871
-7,187
-8% -$521K
UNH icon
90
UnitedHealth
UNH
$396B
$5.99M 0.31%
27,579
-4,307
-14% -$1.04M
CHTR icon
91
Charter Communications
CHTR
$15.7B
$5.93M 0.31%
14,400
-1,652
-10% -$667K
ACN icon
92
Accenture
ACN
$86.2B
$5.86M 0.31%
30,485
-246
-0.8% -$47.6K
RJF icon
93
Raymond James Financial
RJF
$32.7B
$5.76M 0.3%
104,768
+302
+0.3% +$16.4K
MGP
94
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$5.74M 0.3%
190,948
+1,334
+0.7% +$40.1K
FIS icon
95
Fidelity National Information Services
FIS
$21.5B
$5.71M 0.3%
43,010
+638
+2% +$84.7K
PYPL icon
96
PayPal
PYPL
$49.3B
$5.69M 0.3%
54,950
-23,773
-30% -$2.62M
IWO icon
97
iShares Russell 2000 Growth ETF
IWO
$14.9B
$5.59M 0.29%
29,026
+25,957
+846% +$5.15M
SO icon
98
Southern Company
SO
$106B
$5.58M 0.29%
90,374
+13,259
+17% +$769K
AMP icon
99
Ameriprise Financial
AMP
$47.5B
$5.55M 0.29%
37,747
+277
+0.7% +$38.8K
LULU icon
100
lululemon athletica
LULU
$13.2B
$5.5M 0.29%
28,577
-288
-1% -$53.8K

Similar funds

Boston Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Boston Advisors held 683 positions worth $1.91B, up 2.2% from $1.87B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Boston Advisors's Q3 2019 filing shows 51 new, 235 increased, 259 reduced and 87 closed positions. Its largest new stake was L3Harris: 79,883 shares worth $16.7M. The largest sale was Zions Bancorporation, an estimated $7.18M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • Boston Advisors's largest Q3 2019 buy was L3Harris: 79,883 shares worth $16.7M.
  • Boston Advisors added most to AT&T in Q3 2019, an estimated $5.59M increase.
  • Boston Advisors's biggest Q3 2019 reduction was Zions Bancorporation, cutting an estimated $7.18M.
  • Boston Advisors fully exited Mimecast Limited in Q3 2019, selling an estimated $4.37M.
  • Boston Advisors's ten largest holdings make up 16% of its $1.91B portfolio in Q3 2019.
  • Boston Advisors opened 51 new positions and closed 87 in Q3 2019.
  • Boston Advisors's portfolio value rose 2.2% quarter-over-quarter to $1.91B.

Based on Boston Advisors's 13F filing for Q3 2019, filed 5 Nov 2019.